What is Monte Rosa Therapeutics, Inc.'s free cash flow margin?

Monte Rosa Therapeutics, Inc. (GLUE) reported free cash flow margin of -45.8% in Q1 2026.

How has Monte Rosa Therapeutics, Inc.'s free cash flow margin changed year-over-year?

Monte Rosa Therapeutics, Inc.'s free cash flow margin decreased by 339.5% year-over-year, from 19.1% to -45.8%.

What does free cash flow margin mean?

Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.

Monte Rosa Therapeutics, Inc. GLUE Free cash flow margin

Free cash flow margin at other companies

Bristol-Myers SquibbBMY

24.6%-2.9pp

Nurix Therapeutics, Inc.NRIX

-378.7%+24.1pp

Kymera TherapeuticsKYMR

-474%+92.4pp

ImmunomeIMNM

-5,118.9%-8,601pp

Adaptive BiotechnologiesADPT

-10.5%-4.6pp

Arcus BiosciencesRCUS

-207.2%—

Other financials

Income statement

See full

Revenue$4.2M-95.0%

Operating income-$50.0M-214%

Net income-$44.5M-195%

EPS (diluted)-$0.45-179%

Balance sheet

See full

Cash & equivalents$159.9M+104%

Total debt$39.1M-6.7%

Total equity$521.9M+89.7%

Total assets$736.4M+87.3%

Cash flow

See full

Operating cash flow-$37.4M+17.9%

CapEx$1.9M+17.7%

Free cash flow-$39.2M+16.7%

Valuation

See full

Market cap$1.75B+361%

Enterprise value$1.63B+381%

P/S40.7×+38.4×

Profitability

See full

Operating margin-345.2%—

Net margin-302.6%—

Returns & leverage

See full

Return on equity-32.6%—

Debt / equity0.1×-0.1×

Current ratio9.5×+3.9×

Where this comes from

Calculated from Monte Rosa Therapeutics, Inc.’s reported figures.

free cash flow/total revenue=-45.8%

Based on trailing twelve months.

The official record: Monte Rosa Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Monte Rosa Therapeutics, Inc.'s free cash flow margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Monte Rosa Therapeutics, Inc.'s free cash flow margin?: Monte Rosa Therapeutics, Inc. (GLUE) reported free cash flow margin of -45.8% in Q1 2026.
How has Monte Rosa Therapeutics, Inc.'s free cash flow margin changed year-over-year?: Monte Rosa Therapeutics, Inc.'s free cash flow margin decreased by 339.5% year-over-year, from 19.1% to -45.8%.
What does free cash flow margin mean?: Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.